Proton magnetic resonance spectroscopic imaging in neurodegenerative diseases

Norbert Schuff, Peter Vermathen, Andrew A Maudsley, Michael W. Weiner

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Proton magnetic resonance spectroscopic imaging (1H MRSI) was used to investigate changes in brain metabolites in Alzheimer's disease, epilepsy, and amyotrophic lateral sclerosis. Examples of results from several ongoing clinical studies are provided. Multislice 1H MRSI of the human brain, without volume preselection offers considerable advantage over previously available techniques. Furthermore, MRI tissue segmentation and completely automated spectral curve fitting greatly facilitate quantitative data analysis. Future efforts will be devoted to obtain full volumetric brain coverage and data acquisition at short spin-echo times (TE < 30 ms) for the detection of metabolites.

Original languageEnglish
Pages (from-to)800-807
Number of pages8
JournalCurrent Science
Volume76
Issue number6
StatePublished - Mar 25 1999
Externally publishedYes

Fingerprint

neurodegenerative diseases
magnetic resonance imaging
Neurodegenerative Diseases
Protons
nuclear magnetic resonance spectroscopy
Magnetic Resonance Imaging
brain
Brain
metabolites
epilepsy
Amyotrophic Lateral Sclerosis
Alzheimer disease
clinical trials
Epilepsy
data analysis
Alzheimer Disease
methodology

ASJC Scopus subject areas

  • General
  • Agricultural and Biological Sciences(all)

Cite this

Proton magnetic resonance spectroscopic imaging in neurodegenerative diseases. / Schuff, Norbert; Vermathen, Peter; Maudsley, Andrew A; Weiner, Michael W.

In: Current Science, Vol. 76, No. 6, 25.03.1999, p. 800-807.

Research output: Contribution to journalArticle

Schuff, N, Vermathen, P, Maudsley, AA & Weiner, MW 1999, 'Proton magnetic resonance spectroscopic imaging in neurodegenerative diseases', Current Science, vol. 76, no. 6, pp. 800-807.
Schuff, Norbert ; Vermathen, Peter ; Maudsley, Andrew A ; Weiner, Michael W. / Proton magnetic resonance spectroscopic imaging in neurodegenerative diseases. In: Current Science. 1999 ; Vol. 76, No. 6. pp. 800-807.
@article{0c38a5ae2a19474999f23bad6407676f,
title = "Proton magnetic resonance spectroscopic imaging in neurodegenerative diseases",
abstract = "Proton magnetic resonance spectroscopic imaging (1H MRSI) was used to investigate changes in brain metabolites in Alzheimer's disease, epilepsy, and amyotrophic lateral sclerosis. Examples of results from several ongoing clinical studies are provided. Multislice 1H MRSI of the human brain, without volume preselection offers considerable advantage over previously available techniques. Furthermore, MRI tissue segmentation and completely automated spectral curve fitting greatly facilitate quantitative data analysis. Future efforts will be devoted to obtain full volumetric brain coverage and data acquisition at short spin-echo times (TE < 30 ms) for the detection of metabolites.",
author = "Norbert Schuff and Peter Vermathen and Maudsley, {Andrew A} and Weiner, {Michael W.}",
year = "1999",
month = "3",
day = "25",
language = "English",
volume = "76",
pages = "800--807",
journal = "Current Science",
issn = "0011-3891",
publisher = "Indian Academy of Sciences",
number = "6",

}

TY - JOUR

T1 - Proton magnetic resonance spectroscopic imaging in neurodegenerative diseases

AU - Schuff, Norbert

AU - Vermathen, Peter

AU - Maudsley, Andrew A

AU - Weiner, Michael W.

PY - 1999/3/25

Y1 - 1999/3/25

N2 - Proton magnetic resonance spectroscopic imaging (1H MRSI) was used to investigate changes in brain metabolites in Alzheimer's disease, epilepsy, and amyotrophic lateral sclerosis. Examples of results from several ongoing clinical studies are provided. Multislice 1H MRSI of the human brain, without volume preselection offers considerable advantage over previously available techniques. Furthermore, MRI tissue segmentation and completely automated spectral curve fitting greatly facilitate quantitative data analysis. Future efforts will be devoted to obtain full volumetric brain coverage and data acquisition at short spin-echo times (TE < 30 ms) for the detection of metabolites.

AB - Proton magnetic resonance spectroscopic imaging (1H MRSI) was used to investigate changes in brain metabolites in Alzheimer's disease, epilepsy, and amyotrophic lateral sclerosis. Examples of results from several ongoing clinical studies are provided. Multislice 1H MRSI of the human brain, without volume preselection offers considerable advantage over previously available techniques. Furthermore, MRI tissue segmentation and completely automated spectral curve fitting greatly facilitate quantitative data analysis. Future efforts will be devoted to obtain full volumetric brain coverage and data acquisition at short spin-echo times (TE < 30 ms) for the detection of metabolites.

UR - http://www.scopus.com/inward/record.url?scp=0042283220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042283220&partnerID=8YFLogxK

M3 - Article

VL - 76

SP - 800

EP - 807

JO - Current Science

JF - Current Science

SN - 0011-3891

IS - 6

ER -